The FDA-approved type 2 diabetes treatment, Ozempic, which has also found use as a weight loss drug, may have a negative side effect of muscle loss, according to a study published in The Lancet. While the researchers did not advise complete discontinuation of the drug, they recommended strategic use in combination with proper nutrition and exercise to mitigate this side effect.
NSW healthcare provider JewishCare suffers comprehensive data breach
JewishCare NSW, an Australian healthcare provider, reported a major data breach on October 28. The compromised data, which may have been posted on the dark
